Macleods Pharma recalls 1mg Eszopiclone tablets in 30-count bottles due to customer reports of missing tablets. Affected units may have 1-3 tablets missing from the bottle.
“Macleods Eszopiclone Tablets 1mg Recall: Missing Tablets Reported.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/34617-macleods-eszopiclone-tablets-1mg-recall-missing-tablets-reported. Based on FDA recall #D-1174-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1174-2022%22&limit=1).
The FDA announced on June 16, 2022, that Macleods Pharma USA Inc voluntarily recalled Eszopiclone Tablets USP 1 mg due to a shortfill hazard where customers reported missing tablets from 30-count bottles. Owners should contact the company for a remedy.
How to tell if you have it
Brand: Macleods
Product: Eszopiclone Tablets, USP 1 mg
Packaging: 30-count bottles, Rx Only
NDC: 33342-299-07
Lot #: BEK2009A
Expiration: 11/2023
Manufacturer: Macleods Pharma USA, Inc., Plainsboro, NJ 08536
Distributor: Nationwide and Puerto Rico
The hazard
The recall addresses a shortfill issue where customer complaints indicated that one to three tablets were missing from the 30-count bottles. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Macleods Pharma USA, Inc has 20 other recalls on record since December 24, 2015. Recent brand recalls include a February 26, 2026 Levothyroxine Tablets recall for subpotent drug risk and a May 7, 2024 Losartan/HCTZ recall for foreign substance hazards. Other recent recalls of similar products include an August 27, 2026 Macleods Olanzapine Tablets 5mg recall for impurities that may cause harm.
How to tell if you have this one
Check for 30-count bottles of 1 mg Eszopiclone tablets labeled 'Rx Only' with NDC 33342-299-07. The lot number BEK2009A expires November 2023.
Brand
Macleods
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Tablet Count
Count the tablets in the bottle to ensure there are 30 tablets present.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Distributed Nationwide and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1174-2022 (June 16, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1174-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.